Contact this trialFirst, we need to learn more about you.
Antibody-Drug Conjugate
DS-8201a for Breast Cancer
Recruiting2 awardsPhase 2
Honolulu, Hawaii
This trial is testing a new experimental product, DS-8201a, to see if it can help patients with HER-2 positive breast cancer who have not responded to current treatment, or have become resistant to it. DS-8201a is a combination of an antibody and a drug. If it is effective, it could help to slow down tumor growth and improve outcomes for patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.